4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-24-081302
Director sold 584 shares at $40.98 ($23,932)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sanders Corazon (Corsee) D. Director | 2024-07-02 | Sale 10b5-1 | −584 | $40.98 | $23,932 | 12,009 | D: show line 1 in the form |
| Open-market sales · 584 sh · avg $40.98 · $23,932 | |||||||
Loading xslF345X05/ownership.xml…